These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30787614)

  • 1. Mild cognitive decline in type 2 diabetes mellitus patients - risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targets.
    Gul O; Gul S
    Neuropsychiatr Dis Treat; 2019; 15():403-404. PubMed ID: 30787614
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidative stress-mediated influence of plasma DPP4 activity to BDNF ratio on mild cognitive impairment in elderly type 2 diabetic patients: results from the GDMD study in China.
    Zheng T; Liu H; Qin L; Chen B; Zhang X; Hu X; Xiao L; Qin S
    Metabolism; 2018 Oct; 87():105-112. PubMed ID: 29572131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Plasma DPP4 Activity and Brain-Derived Neurotrophic Factor With Moderate to Severe Depressive Symptoms in Patients With Type 2 Diabetes: Results From a Cross-Sectional Study.
    Zheng T; Ge B; Qin L; Chen B; Tian L; Gao Y; Xiao L; Hu X; Pan H; Chen Y
    Psychosom Med; 2020 May; 82(4):350-358. PubMed ID: 32358323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of subclinical atherosclerosis in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study.
    Zheng TP; Liu YH; Yang LX; Qin SH; Liu HB
    Atherosclerosis; 2015 Oct; 242(2):580-8. PubMed ID: 26318108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus.
    Iwabuchi A; Kamoda T; Saito M; Nozue H; Izumi I; Hirano T; Sumazaki R
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1093-7. PubMed ID: 23817599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus.
    Barchetta I; Ciccarelli G; Barone E; Cimini FA; Ceccarelli V; Bertoccini L; Sentinelli F; Tramutola A; Del Ben M; Angelico F; Baroni MG; Lenzi A; Cavallo MG
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1087-1094. PubMed ID: 31431395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study.
    Zheng T; Gao Y; Baskota A; Chen T; Ran X; Tian H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2330-4. PubMed ID: 25029421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship Between Plasma DPP4 Activity to BDNF Ratio and Mild Cognitive Impairment in Elderly Population With Normal Glucose Tolerance.
    Xiao L; Ge B; Chen X; Chen B; Qin L; Hu X; Pan H; Chen Y; Tian L; Gao Y; Zheng T
    Front Aging Neurosci; 2019; 11():33. PubMed ID: 30886577
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database.
    Detournay B; Halimi S; Robert J; Deschaseaux C; Dejager S
    Vasc Health Risk Manag; 2015; 11():417-25. PubMed ID: 26229480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Diffusion Tensor Imaging Study on White Matter Abnormalities in Patients with Type 2 Diabetes Using Tract-Based Spatial Statistics.
    Xiong Y; Sui Y; Xu Z; Zhang Q; Karaman MM; Cai K; Anderson TM; Zhu W; Wang J; Zhou XJ
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1462-9. PubMed ID: 26988810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DPP4 in Diabetes.
    Röhrborn D; Wronkowitz N; Eckel J
    Front Immunol; 2015; 6():386. PubMed ID: 26284071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture.
    Driessen JH; van Onzenoort HA; Henry RM; Lalmohamed A; van den Bergh JP; Neef C; Leufkens HG; de Vries F
    Bone; 2014 Nov; 68():124-30. PubMed ID: 25093264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic vaccine against DPP4 improves glucose metabolism in mice.
    Pang Z; Nakagami H; Osako MK; Koriyama H; Nakagami F; Tomioka H; Shimamura M; Kurinami H; Takami Y; Morishita R; Rakugi H
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1256-63. PubMed ID: 24639549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma dipeptidyl peptidase 4 activities predict new-onset microalbuminuria in association with its proinflammatory effects in Chinese without diabetes: a four-year prospective study.
    Zheng T; Baskota A; Gao Y; Tian H; Yang F
    Nephrol Dial Transplant; 2015 Mar; 30(3):460-6. PubMed ID: 25294850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes.
    Al-Aissa Z; Rosta K; Hadarits O; Harreiter J; Zóka A; Bancher-Todesca D; Patócs A; Kiss K; Sármán B; Pusztai P; Sziller I; Rigó J; Rácz K; Somogyi A; Kautzky-Willer A; Firneisz G
    Eur J Clin Invest; 2015 Feb; 45(2):196-203. PubMed ID: 25556541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging roles of dipeptidyl peptidase 4 inhibitors: anti-inflammatory and immunomodulatory effect and its application in diabetes mellitus.
    Yang L; Yuan J; Zhou Z
    Can J Diabetes; 2014 Dec; 38(6):473-9. PubMed ID: 25034244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of DPP4 inhibitors on the levels of plasma catecholamines and their metabolites in patients with type 2 diabetes.
    Kim TH; Lee K; Park IB; Choi CS; Ahn TH; Lee DH
    Diabetes Res Clin Pract; 2019 Oct; 156():107832. PubMed ID: 31513823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.
    Zhong J; Maiseyeu A; Davis SN; Rajagopalan S
    Circ Res; 2015 Apr; 116(8):1491-504. PubMed ID: 25858071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus.
    Lee SA; Kim YR; Yang EJ; Kwon EJ; Kim SH; Kang SH; Park DB; Oh BC; Kim J; Heo ST; Koh G; Lee DH
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2553-61. PubMed ID: 23539735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin.
    Wilson JR; Shuey MM; Brown NJ; Devin JK
    J Endocr Soc; 2017 Sep; 1(9):1168-1178. PubMed ID: 29264572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.